Daily Press – In a two-year span, the nation’s only licensed anthrax vaccine maker went from pleading poverty to announcing $100 million in acquisitions, including other pharmaceutical companies and a new manufacturing plant near Washington, D.C.
It’s a pattern that’s worked well for BioPort Corp.: Tell the Pentagon or Congress that it doesn’t have the money to keep going, negotiate a new deal, then count the extra cash rolling in.
more…
BiodefenseEducation.org is curated by Donna M. D'Alessandro, M.D. and Michael P. D'Alessandro, M.D.
Please send us comments by filling out our Comment Form.
All contents copyright © 2003-2009 by Donna M. D'Alessandro, M.D. and Michael P. D'Alessandro, M.D. All rights reserved.
'BiodefenseEducation.org' is a Trademark of Donna M. D'Alessandro, M.D. and Michael P. D'Alessandro, M.D.
BiodefenseEducation.org is part of The University of Iowa's Planning Regional Center of Excellence for Biodefense and Emerging Infectious Diseases and is funded in part by a grant from the National Institute of Health's National Institute of Allergy and Infectious Diseases. Advertising is not accepted.
Your personal information remains confidential and is not sold, leased, or given to any third party be they reliable or not.
This site complies with the HONcode standard for trustworthy health information:
verify here.
The information contained in BiodefenseEducation.org is not a substitute for the medical care and advice of your physician. There may be variations in treatment that your physician may recommend based on individual facts and circumstances.
URL: http://www.biodefenseeducation.org/